title: A century in the making… almost here?
abstract: Cancer immunotherapeutics, including vaccines, may hit the market by the end of this decade. They promise longer survival and perhaps indefinite remission at a more favorable cost-benefit ratio than that of oncologics now in use. They also may fuel dramatic changes in how healthcare is delivered and financed.
authors.forename: Katherine T
authors.initials: KT
authors.lastname: Adams